CareRx Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, CareRx stock has a consensus rating of "Buy" and an average price target of $5.14. The average 1-year stock price forecast is 58.64% higher than the current stock price, while the lowest is $4.25 (+31.17%) and the highest is $6.25 (+92.90%).

Price Target: $5.14 (+58.64%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.25	$5.14	$5.00	$6.25
Change	+31.17%	+58.64%	+54.32%	+92.90%

* Price targets were last updated on May 11, 2026.

Analyst Ratings

The average analyst rating for CareRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	4
Buy	3	3	2	2	2	2
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kyle McPhee ATB Cormark Capital Markets	ATB Cormark Capital Markets	Buy Maintains $6.25	Buy	Maintains	$6.25	+92.90%	May 11, 2026
Justin Keywood Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $4.50	Buy	Maintains	$4.50	+38.89%	May 8, 2026
David Martin PhD Bloom Burton	Bloom Burton	Buy Maintains $5.50 → $5.00	Buy	Maintains	$5.50 → $5.00	+54.32%	May 8, 2026

Financial Forecast

Revenue This Year

384.72M

from 370.24M

3.91%

from 370.24M

Revenue Next Year

406.34M

from 384.72M

5.62%

from 384.72M

EPS This Year

0.17

from 0.04

313.63%

from 0.04

EPS Next Year

0.25

from 0.17

45.10%

from 0.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	262.63M	381.73M	370.75M	366.71M	370.24M	384.72M
Revenue Growth	61.92%	45.35%	-2.88%	-1.09%	0.96%	3.91%
Gross Profit	75.28M	109.93M	104.70M	108.06M	110.96M	116.19M
Gross Margin	28.66%	28.80%	28.24%	29.47%	29.97%	30.20%
Net Income	-22.73M	-34.35M	-5.41M	-4.50M	26.13M	5.65M
EPS	-	-	-	-	0.04	0.17
EPS Growth	-	-	-	-	26.46%	313.63%
Forward PE	-	-	-	42.21	22.74	19.06
Free Cash Flow	-14.85M	7.32M	6.63M	23.49M	16.36M	15.70M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.

Revenue Forecast

Revenue	2026	2027	2028
High	392.3M
Avg	384.7M
Low	378.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.0%
Avg	3.9%
Low	2.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.17
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	313.6%
Low	-